Rami Doukky to Treatment Outcome
This is a "connection" page, showing publications Rami Doukky has written about Treatment Outcome.
Connection Strength
0.999
-
Invasive therapy versus conservative therapy for patients with stable coronary artery disease: An updated meta-analysis. Clin Cardiol. 2021 May; 44(5):675-682.
Score: 0.098
-
BRASH Syndrome with Hyperkalemia: An Under-Recognized Clinical Condition. Methodist Debakey Cardiovasc J. 2020 Jul-Sep; 16(3):241-244.
Score: 0.093
-
The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation. J Nucl Cardiol. 2019 06; 26(3):814-822.
Score: 0.077
-
Impact of integrating heart rate response with perfusion imaging on the prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017 10; 24(5):1666-1671.
Score: 0.070
-
Impact of Dietary Sodium Restriction on Heart Failure Outcomes. JACC Heart Fail. 2016 Jan; 4(1):24-35.
Score: 0.068
-
The prognostic value of transient ischemic dilatation with otherwise normal SPECT myocardial perfusion imaging: a cautionary note in patients with diabetes and coronary artery disease. J Nucl Cardiol. 2013 Oct; 20(5):774-84.
Score: 0.058
-
Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease--the ASSUAGE-CKD trial. Int J Cardiovasc Imaging. 2013 Jun; 29(5):1029-37.
Score: 0.055
-
Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. "The ASSUAGE trial". J Nucl Cardiol. 2012 Jun; 19(3):448-57.
Score: 0.052
-
Chronological comparison of TAVI and SAVR stratified to surgical risk: a systematic review, meta-analysis, and meta-regression. Acta Cardiol. 2023 Sep; 78(7):778-789.
Score: 0.029
-
Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction. Am J Cardiol. 2023 01 15; 187:84-92.
Score: 0.028
-
Feasibility and safety of laser balloon pulmonary vein isolation in patients with prior left atrial appendage occlusion device implantation. J Cardiovasc Electrophysiol. 2022 11; 33(11):2389-2393.
Score: 0.027
-
Abbreviated versus Standard Duration of DAPT after PCI: A Systematic Review and Network Meta-analysis. Am J Cardiovasc Drugs. 2022 Nov; 22(6):633-645.
Score: 0.027
-
Novel oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2022 06; 99(7):2101-2110.
Score: 0.026
-
Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials. Am Heart J. 2020 12; 230:71-81.
Score: 0.024
-
Cochrane corner: transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Heart. 2020 07; 106(14):1043-1045.
Score: 0.023
-
Systematic review and meta-analysis of current risk models in predicting short-term mortality after transcatheter aortic valve replacement. EuroIntervention. 2020 Apr 17; 15(17):1497-1505.
Score: 0.023
-
Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Cochrane Database Syst Rev. 2019 12 20; 12:CD013319.
Score: 0.022
-
Fragility Index in Cardiovascular Randomized Controlled Trials. Circ Cardiovasc Qual Outcomes. 2019 12; 12(12):e005755.
Score: 0.022
-
Impact of chronic thrombocytopenia on in-hospital outcomes and healthcare resource utilization after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 08; 96(2):413-421.
Score: 0.022
-
Quadripolar versus bipolar leads in cardiac resynchronization therapy: An analysis of the National Cardiovascular Data Registry. Heart Rhythm. 2020 01; 17(1):81-89.
Score: 0.022
-
Meta-Analysis of the Effect of Preoperative Atrial Fibrillation on Outcomes After Left Ventricular Assist Device Implantation. Am J Cardiol. 2019 07 01; 124(1):158-162.
Score: 0.021
-
Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR. J Cardiovasc Magn Reson. 2018 12 20; 20(1):87.
Score: 0.021
-
Coming-of-age: The ImageGuide? Registry at three. J Nucl Cardiol. 2019 02; 26(1):72-75.
Score: 0.021
-
Design of a bilevel clinical trial targeting adherence in heart failure patients and their providers: The Congestive Heart Failure Adherence Redesign Trial (CHART). Am Heart J. 2018 Jan; 195:139-150.
Score: 0.019
-
Indirect Comparison of Novel Oral Anticoagulants in Women with Nonvalvular Atrial Fibrillation. J Womens Health (Larchmt). 2017 03; 26(3):214-221.
Score: 0.018
-
The Impact of Hospital and Surgeon Volume on In-Hospital Mortality of Ventricular Assist Device Recipients. J Card Fail. 2016 Mar; 22(3):226-31.
Score: 0.017
-
Congestive heart failure adherence redesign trial: a pilot study. BMJ Open. 2014 Dec 04; 4(12):e006542.
Score: 0.016